The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. RenovoRx Inc shares valued at $13,500 were purchased by Agah Ramtin on Apr 15 ’25. At $0.90 per share, Agah Ramtin acquired 15,000 shares. The insider’s holdings grew to 1,113,460 shares worth approximately $1.14 million following the completion of this transaction.
Also, Bagai Shaun purchased 7,500 shares, netting a total of over 6,821 in proceeds. Following the buying of shares at $0.91 each, the insider now holds 320,040 shares.
Before that, Agah Ramtin had added 20,000 shares to its account. In a trade valued at $16,000, the Chief Medical Officer bought RenovoRx Inc shares for $0.80 each. Upon closing the transaction, the insider’s holdings increased to 20,000 shares, worth approximately $1.12 million.
Analyzing RNXT Stock Performance
During the last five days, there has been a surge of approximately 28.95%. Over the course of the year, RenovoRx Inc shares have dropped approximately -20.93%. Shares of the company reached a 52-week high of $1.6899 on 01/21/25 and a 52-week low of $0.7500 on 04/07/25. A 50-day SMA is recorded $0.9899, while a 200-day SMA reached $1.1236.
Support And Resistance Levels for RenovoRx Inc (RNXT)
According to the 24-hour chart, there is a support level at 0.9867, which, if violated, would cause prices to drop to 0.9533. In the upper region, resistance lies at 1.0467. The next price resistance is at 1.0733. RSI (Relative Strength Index) is 56.89 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0891, which suggests the price will decrease in the coming days. Percent R is at 6.90%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
